Here, we describe the development of an inducible MYB-NFIB fusion model based on MYB breakpoint sites identified from t(6;9) translocation positive patient-derived xenograft and patients’ tumors of ACC. The gene discussed is MYB; the disease is adrenal cortex carcinoma.